Kenichi Ta naka, MD, MSC

• Associate Professor
• Anesthesiology
• Emory University School of Medicine
• Atlanta, Georgia

The development of a standard set of functions is an important component in the robustness of biological systems erectile dysfunction treatment cost in india order cheapest zydalis and zydalis. This is a logical concept for membrane-bounded compartments such as mitochondria erectile dysfunction young male causes zydalis 20 mg purchase visa, lysosomes erectile dysfunction 50 purchase zydalis 20 mg mastercard, etc impotence juice recipe order zydalis 20 mg otc. In each of those cases erectile dysfunction at age of 20 effective 20 mg zydalis, a complex function can operate in a confined region of cytoplasm to fulfill a set of tasks. Such independent complex functions can respond to perturbations without direct interference from other functional activities. This implies two aspects of the cellular compartments: (1) localization, and (2) modularity. The small size of most proteins (2­20 nm) means that the functions can be performed within limited spatial and temporal scales (localized). If functions were to involve much larger scales, then there can be significant interference between complex functions. In addition, functions are modular and the organelle that performs a complex function in one cell type can be easily adapted to perform the same complex function in a different cell background by the propagation of that organelle. Thus, the operational aspects of the functions should be isolated so that they can do the desired task; but control and communication signals between compartments are needed to integrate functions in the cell context. Knowing the complex functions performed in each of the major cell compartments provides a perspective on how various tasks are apportioned in cells (for more details please see cell biology textbooks, such as Alberts et al. Principles of Robust Complex Functions Compartmentalization of complex functions (localized and modular). Complex functions are either on or off (rates are typically not continually adjusted). Term limits (complex functions turn off after relatively short periods and need to be turned on). The large volume of material transported between the nucleus and cytoplasm means that a transport mechanism is needed to link the two compartments. An unusual feature of the nucleus is the way in which it is separated from the cytoplasm. They need to be transported into the lumen as others are transported back to the cytoplasm to maintain a balance. Processing is progressive from one stack to another and there is a debate about whether movements between membranes depend upon the flow of membrane or by formation of vesicles at one stack that then fuse to the next stack. Microtubules and microtubule motors help to organize a central Golgi around the microtubule organizing center(s) that anchors the microtubules. The Golgi apparatus is the primary site for carbohydrate modification of cell surface glycoproteins, soluble cytokines, and extracellular matrices. Secreted, large carbohydrate domains are porous polymers that help to lubricate cell­cell contact regions and by their shear mass keep the membranes apart while allowing small molecules to reach the cell surface. Changes in metabolism produce dramatic changes in mitochondrial morphology that belie complex mechanisms for mitochondrial fragmentation and transport. In addition, mitochondria provide a trigger for cell suicide by catalyzing apoptotic cell death pathways when their outer membrane is opened and cytochrome c leaks into the cytoplasm. Cell lines have been generated without mitochondria; however, they are relatively weak because of the greater efficiency afforded by mitochondria. Mitochondria have become a target of drug delivery research to specifically induce cancer cell death. Using fluid-phase or plasma membrane markers, researchers have found that an area of membrane equal to the plasma membrane is taken up every 33 2. Early endosomes form by several different mechanisms including by fission of recently endocytosed vesicles and the folding back of membrane veils onto the cell surface to form macropinosomes. Proteins are sorted in early endosomes to go either back to the plasma membrane or to move on in the endocytic pathway eventually to lysosomes. Small vesicles and membrane tubules carry membrane back to the plasma membrane and the residue destined for late endosomes moves by microtubule motors on microtubules to an area of the Golgi called the trans-Golgi network. Late endosomes further sort inactive proteins or nutrients for movement on to the lysosomes, whereas many components including most lipids move back to the plasma membrane. Sodium-proton exchange proteins acidify the lumen of the endosomes to aid in the aggregation of many proteins that become neutral at acidic pH. A complex set of factors including membrane curvature, pH, protein concentration, and bilayer asymmetry go into the sorting decisions. It is clear that the sorting process is critical for refreshing plasma membrane proteins, hormone receptors, and for the uptake of nutrients. Endosomes are also an important means for cells to adapt to environments via receptor recycling to dampen cellular responses to extracellular signals. Over the past decade, the endosome has been exploited for delivery of drugs and genes to cells. Further, technologies to block endosome uptake of virus and other pathogens have also been developed. The acidic lysosome (pH 4­5) contains many hydrolases and proteases that are only active at low pH. If they leak into the cytoplasm, the neutral pH will inhibit their activity and minimize the damage they would otherwise cause. The factors that target material to the lysosome are poorly understood; however, in addition to material from late endosomes, aggregates of improperly folded proteins will be covered with membrane and fused to lysosomes in the process of autophagy. As in the macroscopic world, there is less interest in the garbage disposal process in cells than in other processes. This is a very specialized compartment that was formed for a particularly complex function and there appears to be no redundancy. Metabolic organs like the liver contain highly specialized hepatocytes that are full of peroxisomes. Membranes are not part of the formation of these compartments and small components can freely diffuse between them. However, large cytoplasmic vesicles are sequestered in endoplasm, the core of cytoplasm around the nucleus that contains all of the microtubules responsible for the transport of vesicular organelles. In contrast, the peripheral ectoplasm is normally a thin layer that is organized by actin filaments that assemble at the plasma membrane normally and move inward where they depolymerize. Vesicular organelles in the endoplasm are physically unable to reach the plasma membrane because of the much smaller gaps in the actin network of the ectoplasm. Hormone signals can rapidly alter the volume of the ectoplasm and thereby rapidly increase or decrease secretory vesicle interactions with the plasma membrane. There is considerable structure to the cytoplasm and many of the components of cells are concentrated in specific cytoplasmic regions. Molecular components that are involved in a particular complex function are often co-localized as a robust functional module. Those modules may not formally be compartments, but they can often act as a compartment. The localized and modular nature of the compartmentalized complex functions that is stochastic but yields deterministic emergent properties make the complex functions resilient to local disturbances and are thus robust. For example, transcription and translation and protein modifications are different complex functions occurring in different compartments. Within each compartment, the stochastic nature of the complex function is suppressed by error-checking and by integrative processes that make the output less sensitive to fluctuations in individual events. When integrative signaling components exceed a certain threshold, a decision is made that constitutes a deterministic output. Segregating different complex functions into different physical compartments increases the decision points that will filter out the noise or compensate for the failure of an individual event. However, there is often coordination between compartments in a particular context that gives rise to emergent (observable) properties of the system through forces, positioning, and chemical signals to enable many multifaceted tasks to be completed. For a given cell, we should be able to predict its behavior if we know which complex cellular functions are active and how those functions communicate with other functions of the cell to produce emergent properties. Because a finite number of complex functions are active in any given cell (probably in the range of 100s), the task of being able to predict the cellular behavior is feasible. This needs to be qualified by the realization that each complex function is stochastic and will produce a range of outputs. Proteins in the adhesions are modified and move to the nucleus where they will alter transcriptional patterns. Further, adhesion proteins can activate kinases that will stimulate entry into the cell cycle, which will also produce signals to the nucleus that affect transcription as well as altering cell metabolism. As we understand the functional compartments and the ways that they communicate with each other, we can develop diagrams to model how the pattern of inputs can affect the specific set of functions that are activated and the pattern of outputs that will cause further changes. The simpler scheme that appears to be true is that Topo1 has both sensory and catalytic activities and can act alone. There are other cases where the mechanosensing and the enzymatic activities reside in different proteins, but in this case the one protein can perform both functions. Further, signaling and communication between different systems also should be by the simplest mechanism. In the case of the endocytosis and exocytosis systems, there must be communication to regulate the surface area of the cell. This is a difficult task because there are multiple secretory pathways adding membrane and multiple endocytic pathways taking it inside the cell. Hypothetically, the hundreds of proteins involved in exocytosis and endocytosis could communicate through a master regulator that would balance the outward and inward flows. Alternatively, the physical tension in the membrane could directly control the rate of endocytosis, decreasing endocytosis with high tensions and increasing it with low. Indeed, several studies have shown that tension in the membrane controls the rate of endocytosis and hypotonic shock (or a rise in tension) can trigger rapid exocytosis. From this and other cases, the simplest signaling systems are often physical or mechanical in nature. It is common to start with the simplest hypothesis to explain the results and only move to a more complex hypothesis when the simple one is proven wrong. If more is needed, then the function is turned on again until the desired output level is reached. The activation of the function is then tied to a sensory system that only needs to measure one level, i. In the On state, the complex function operates in a standard way that is altered by the availability of substrates or other factors, but there does not appear to be continual adjustment in the rate through complex feedback mechanisms. The latter method is much more complex and could fail in many more ways than the first method. Complex Functions of Robust Machines with Emergent Properties method, there will naturally be larger fluctuations in the level of the protein, but cells are not sensitive to the exact levels of most proteins. Further, the length of the On state affects how often the function needs to be turned on, but if mutations alter the On time, the system will easily compensate. Thus, the cell can perform a complex function multiple times to produce the same level of output as if the complex function is always on but the rate is adjusted. The limitation comes if there is a major demand that exceeds the output rate of the functional modules, which should then cause an increase in the capacity through an increase in the number of modules. Recent analyses of a number of complex functions including motile, metabolic and growth functions find that they are digital when studied at a single cell level. When analyzed at a population level, there are intermediate levels (analog), but that is the result of the fact that the complex function is only active in a fraction of the cells in the population. The advantage of regulating complex functions and functional modules in a digital fashion is that cells do not have to develop an analog regulator of rate. Only the On signal is needed and that can be tuned to the level of the output parameter that is needed. This necessarily results in a range of functional outputs when observed at a single cell level in a population of cells in different states. If we look at the levels of a given protein in single cells, there are often wide variations (particularly in bacteria) that make it seem like something is wrong. As robust systems, the levels of a single protein are not often important (there are exceptions) and the cells in a population can be in many different states (different phases of the cell cycle, senescent, or in a different morphology). Thus, a digital control of protein production and many other parameters enables cells to perform properly and the digital control systems are relatively easier to design as well as being more robust. In the political realm, term limits regulate the length of time that any given politician can be in office. Similarly, cells find it useful to automatically turn off a complex function after a period of time. The complex function then will not automatically run and the cell must activate it again for further output. As most complex functions utilize energy or resources, the organism conserves energy or resources by having complex functions that will automatically turn off. For example, motile functions are normally characterized by intermittent activity. Organelle movements on microtubules are saltatory in that the vesicular organelles only move a short distance before they stop and then they start moving again. Actin-based motility is similar in that edge protrusions are limited and stochastic. Cells migrate by a series of limited extension events and often stop moving, round up and restart migration. In all of these cases, the cells use an automatic turn-off mechanism rather than developing an analog system to regulate the output. Automatic turn-off has a number of obvious consequences for people who are studying complex cellular functions in vitro. Because the default state is off and the system is only on for a limited period, it is difficult to study in vitro as the in vivo activation signals might not be preserved in test tubes. Experimenters have developed ways to override the off switches in several cases, but that gives an unrealistic view of the normal cell functions. My own studies of vesicle motility in vitro have always been hampered by our inability to develop in vitro motility assays that would be relevant to cellular vesicle transport. This design feature of biological functions is perhaps underappreciated and runs counter to our thinking. Basically, robust systems should not persist in an On state unless they absolutely need to be on for the survival of the organism.

Rhabdomyosarcoma is a tumor with skeletal muscle differentiation and is primarily a pediatric cancer erectile dysfunction ultrasound protocol zydalis 20 mg purchase on line, described in Chapter 47 erectile dysfunction green tea zydalis 20 mg with amex. All three are represented in adults but the pleomorphic variant is overrepresented in adults erectile dysfunction causes of discount zydalis 20 mg with visa. Multimodal therapy with surgery erectile dysfunction caused by statins zydalis 20 mg without a prescription, chemotherapy erectile dysfunction at age 28 cheap zydalis 20 mg buy, and radiation is required to eradicate primary and micrometastatic disease. The outcome of adults with rhabdomyosarcoma is worse and likely due to an overrepresentation of the pleomorphic histology [81]. Patients who are enrolled in clinical trials appeared to benefit more than nontrial patients [82]. Chemotherapy typically used includes cyclophosphamide, dactinomycin or doxorubicin, and vincristine, with or without ifosfamide and etoposide. Surveillance Surveillance includes followup physical examination and imaging of the primary site and, if necessary, distant sites. For example, desmoid tumors and welldifferentiated liposarcoma typically have local recurrence and thus extensive imaging of distant sites may not be useful. Imaging is performed every 2­4 months during the first 2 years and less frequently after that. While the risk of recurrence decreases beyond 3 years, continued surveillance is recommended for an additional 5 years. Do radiationassociated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas Occupational chlorophenol exposure and soft tissue sarcoma risk among men aged 30­60 years. Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and 9 10 11 12 13 14 dioxins. Decreased cancer risk in patients who have been operated on with total hip and knee arthroplasty for primary osteoarthrosis: a metaanalysis of 6 Nordic cohorts with 73,000 patients. Monogenic and polygenic determinants of sarcoma risk: an international genetic study. The treatment of softtissue sarcomas of the extremities: prospective randomized evaluations of (1) limbsparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Low grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3tier and 4tier grading systems. Resection of the sciatic, peroneal, or tibial nerves: assessment of functional status. Frontline extended surgery is associated with improved survival in retroperitoneal low to intermediategrade soft tissue sarcomas. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Retroperitoneal 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 softtissue sarcoma: analysis of 500 patients treated and followed at a single institution. Predicting outcome by growth rate of locally recurrent retroperitoneal liposarcoma: the one centimeter per month rule. Preoperative versus postoperative radiotherapy in softtissue sarcoma of the limbs: a randomised trial. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Impact of intensitymodulated radiation therapy on local control in primary softtissue sarcoma of the extremity. Local control comparison of adjuvant brachytherapy to intensitymodulated radiotherapy in primary highgrade sarcoma of the extremity. Adjuvant chemotherapy for localised resectable softtissue sarcoma of adults: metaanalysis of individual data. A systematic metaanalysis of randomized controlled trials of adjuvant chemotherapy for localized resectable softtissue sarcoma. The impact of chemotherapy on the survival of patients with highgrade primary extremity liposarcoma. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. Short, fulldose adjuvant chemotherapy in highrisk adult soft tissue sarcomas: a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group. Resection of pulmonary metastases from sarcoma: can some patients benefit from a less invasive approach Longterm results of tumor necrosis factor alpha and melphalanbased isolated limb perfusion in locally advanced extremity soft tissue sarcomas. Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft tissue sarcoma: an openlabel phase 1b and randomised phase 2 trial. Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, openlabel, multicentre, phase 3 trial. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. Molecular basis for primary and secondary tyrosine kinase inhibitor resistance in gastrointestinal stromal tumor. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. Extraabdominal primary fibromatosis: Aggressive management could be avoided in a subgroup of patients. Adult rhabdomyosarcoma survival improved with treatment on multimodality protocols. Patients with a wide variety of cancer types are represented, so the clinical and pathologic findings vary widely. Occasionally, metastatic melanoma or sarcoma can be diagnosed without an obvious primary tumor site; patients with these tumors should be managed following guidelines for the specific tumor type. Further pathologic evaluation is indicated in most cancers of unknown primary site, and should be directed by the initial histologic diagnosis. Histologic examination remains the gold standard for initial evaluation, providing a practical classification system on which to base further testing. Therefore, surgical or core needle biopsies are recommended and use of fineneedle aspiration biopsy for diagnosis should be avoided. In patients with the initial diagnosis of "poorly differentiated neoplasm," establishment of tumor lineage is essential. Several highly treatable tumor types are contained within this group, the most common being nonHodgkin lymphoma, present in 35­65% of cases [2, 3]. Most of the remaining patients have poorly differentiated carcinoma, including neuroendocrine carcinoma. Immunohistochemical staining is almost always successful in identifying the tumor lineage (Table 44. Since adenocarcinomas share histologic features, routine histology is usually unable to predict the primary site. Although certain histologic features have been associated with particular tumor types. As the treatment of adenocarcinomas from various primary sites improves and becomes more specific, accurate prediction of the primary site becomes increasingly important. Gene expression profiling also allows prediction of a site of origin in most cases, and often provides additional diagnostic information. Both modalities should now be considered in the pathologic evaluation of adenocarcinoma of unknown primary site. Appropriate clinical evaluation is important in these patients, since many have highly effective treatment available. The diagnosis is usually made by routine histology, and additional pathologic studies are rarely necessary. Poorly differentiated carcinomas can be recognized histologically, but no further subtyping. Although fewer tumors of other lineages are found in this group, additional evaluation occasionally reveals an unsuspected lymphoma or a germ cell tumor. Improved pathologic diagnosis has resulted in increased recognition of these tumors. Welldifferentiated or lowgrade neuroendocrine tumors have histologic features similar to gastrointestinal carcinoids or pancreatic neuroendocrine tumors (islet cell tumors). These tumors usually have an indolent biology, and frequently secrete bioactive substances. One of these groups has histologic features typical of small cell carcinoma or atypical carcinoid. Immunohistochemistry Immunohistochemical staining is a widely available specialized technique for classifying neoplasms. Electron microscopy is usually successful in identifying the lineage of poorly differentiated neoplasms, particularly in the distinction among carcinoma, lymphoma, and poorly differentiated sarcoma. However, electron microscopy cannot predict the site of origin of various adenocarcinomas. In patients with poorly differentiated neoplasms who have features suggestive of one of these diagnoses, and are undiagnosed after complete pathologic evaluation, testing for a tumorspecific chromosomal abnormality should be considered. Demonstration of one of these specific abnormalities can also provide confirmation if one of these tumor types is unexpectedly identified by gene expression profiling. Gene Expression Tumor Profiling Specific gene expression profiles are now recognized in cancers based on their site of origin, reflecting the different gene expression profiles present in the normal tissues of origin [20]. The potential application of these findings to cancer diagnosis was first demonstrated when differences in gene expression allowed distinction of acute myeloid leukemia from acute lymphoblastic leukemia [21]. These assays measure gene expression dynamics in relation to cell lineage, rather than tumorspecific markers; this method is effective since most cancer cells retain at least part of the gene expression profile of their tissue of origin [25]. When tested in a blinded fashion, these assays were able to accurately identify the tissue of origin in 85­90% of patients with advanced cancers of known primary site. In a group of 24 such patients, identified retrospectively, the prediction of tissue of origin by gene expression profiling matched the clinically identified primary site in 18 (75%) [26]. Three of the remaining 6 patients had an unsuccessful assay due to poor tissue preservation, and 3 patients had an incorrect prediction by the assay. Although confirmation of "accuracy" was impossible in these retrospective series, since anatomic primary sites were never identified, similar findings emerged from all studies: (i) a tissue of origin was predicted in a large percentage of cases, (ii) the tissue of origin prediction was usually consistent with clinical and pathologic features, and (iii) response to empiric chemotherapy and survival were usually generally consistent with the tumor type predicted. Of the 289 patients enrolled in the trial, 252 (87%) had successful assays performed (unsuccessful assays were due to insufficient amounts of tumor in the biopsy specimen). When the assay was successfully performed, a site of origin was predicted in 247 of 252 patients (98%). Twentysix different primary sites were predicted; however, the four most commonly predicted sites (biliary tract, urothelial, colorectal, and nonsmall cell lung cancer) accounted for 55% of all patients. The results of assay directed, sitespecific treatment are detailed in the "Treatment" section of this chapter. A group of 35 patients had additional 650 Cancer of Unknown Primary, Paraneoplastic Syndromes, and Peritoneal Carcinomatosis clinical or pathologic evaluation in an attempt to confirm the molecular cancer classifier assay prediction; in 26 of these patients (74%), additional test results suggested or confirmed the profiling prediction. Gene expression profiling established the tumor lineage in 25 of 30 patients (83%), and suggested the tissue of origin in all 10 carcinomas. All 7 patients who received sitedirected therapy based on the gene expression profiling diagnoses (germ cell 2, neuroendocrine 2, mesothelioma 2, lymphoma 1) responded, and 5 remained alive and diseasefree after 25+ to 72+ months. The current body of evidence supports several conclusions regarding gene expression profiling for diagnosis. The accuracy of these predictions (80­85%) is similar to the blinded validation studies, where the molecular cancer classifier assays were tested using metastatic lesions from cancers of known primary site. Selection of treatment based on molecular profiling assay results has now been tested, and these results are detailed in the "Treatment" section. Additional clinical evaluation should be triggered in specific patients by clinical or pathologic results during the initial evaluation (Table 44. In these patients, additional focused evaluation may: (i) identify a primary site, (ii) narrow the spectrum of possible primary sites, or (iii) identify specific treatable subsets of patients (see section "Treatable Subsets"). Unlike other cancers presenting with an unknown primary site, squamous cell carcinoma almost always presents with isolated metastases in either the cervical or the inguinal lymph nodes. If the primary site cannot be identified by the initial clinical evaluation, it is unlikely to become apparent during the subsequent clinical course (only 5­10%). However, a primary site can be identified in approximately 75% of patients at autopsy [40, 41]. Primary sites in the gastrointestinal tract (pancreas, colorectum, liver) and lung account for approximately 60% of the primary sites identified in autopsy series, whereas primary sites in the ovary, breast, or prostate have been uncommon. Recently, primary sites predicted by molecular profiling have been generally similar, although the numbers of breast, ovarian, and urothelial cancers have been higher [32]. Cancer of Unknown Primary Site 651 frequently do well with appropriate therapy; therefore, the initial diagnostic evaluation is of particular importance. Unilateral cervical adenopathy is the most common presentation of squamous cell carcinoma of unknown primary site. Patients often have a history of tobacco and/or alcohol use, although some of these lesions are associated with human papillomavirus infection. Upper and midcervical lymph nodes are most frequently involved, and in these situations a primary tumor in the head and neck region is likely. Appropriate clinical evaluation includes direct endoscopy with visual examination of the oropharynx, hypopharynx, nasopharynx, larynx, and upper esophagus, and biopsy of any suspicious areas. With this evaluation, primary sites in the head and neck are detected in the large majority of patients; in one study, primary sites were found in 231 of 267 patients (87%) presenting with metastatic squamous carcinoma in cervical nodes [45]. Ipsilateral tonsillectomy is recommended as a diagnostic modality in patients with metastatic involvement of a single subdigastric, midjugulocarotid, or submandibular lymph node. Bilateral tonsillectomy has been recommended in patients with bilateral subdigastric adenopathy [46]. In one series, 26% of patients presenting in this manner had a tonsillar primary identified at the time of tonsillectomy [47].

Zydalis 20 mg purchase amex. Therapies for Non-psychogenic Erectile Dysfunction.

Atherosclerosis is characterized by thickening of the inner surface of the blood vessel wall (intima) due to the accumulation of fatty material and the deposition of calcium erectile dysfunction stress buy discount zydalis 20 mg on-line. Infiltration by monocytes and macrophages occurs erectile dysfunction reviews buy discount zydalis 20 mg online, followed by proliferation of smooth muscle cells from the media erectile dysfunction ultrasound order 20 mg zydalis amex. As a result erectile dysfunction treatment supplements cheap zydalis 20 mg buy online, the vessel walls become thicker and harder and the lumen is reduced erectile dysfunction 40 year old man 20 mg zydalis purchase with visa, potentially reducing the net blood flow. Furthermore, ulceration can develop in the plaque; plaque fragments break free and are entrained by the blood flow, potentially causing embolisms. Embolism is also possible as a consequence of the development of thrombosis on the plaque. Such embolisms cause occlusion of smaller (themselves often sclerotic) vessels distal to their origin, potentially resulting in infarction. Moreover, the fibrous material is liable to tear, leading to haemorrhaging within the plaque and thus to constriction of the lumen, causing a major infarction in that region. In the sections of the blood vessel adjacent to the stenosis, the elasticity of the walls is reduced and the internal elastic lamina is liable to tear, enabling an aneurysm (7sect. Factors that promote atherosclerosis are hypertension, hypercholesterolemia, diabetes mellitus and smoking. Hormonal factors are relevant insofar as atherosclerosis is more common in young men than young women. Atherosclerosis occurs mainly in larger arteries and is therefore often referred to as arteriosclerosis. Atherosclerosis is particularly likely at bifurcation points in the arterial system. Another relevant disorder is arteriolosclerosis: stenosis of the smaller distal blood vessels due to homogenous thickening of the vessel wall. It is strongly associated with hypertension and diabetes mellitus and its neurological consequences are lacunar infarction (7sect. Aneurysms have various possible causes, including atherosclerosis, traumatic or spontaneous dissection of the vessel wall, microbial infection of the vessel wall, systemic disease involving vasculitis, and abnormally high blood flow (due to arteriovenous malformation; 7sect. Congenital aneurysms are very rare, but genetic factors do play a role in the development of aneurysms during life. A cavernoma consists of a dilated vascular structure with thin collagenic vessel walls, forming a spaceoccupying process within brain tissue. They occur mainly in the cerebellum, in the pons and at subcortical locations within the hemispheres. Telangiectasias are dilations in capillary blood vessels, which (unlike cavernomas) weave through the nerve tissue, but do not normally cause clinical symptoms. Cerebral aneurysms occur mainly around the circle of Willis and in the middle cerebral artery (. The location of such aneurysms between the arachnoidea and the pia mater means that they are liable to cause a subarachnoid haemorrhage (7sect. The likelihood of a patient having an aneurysm is greater if other family members have suffered subarachnoid haemorrhages, and in cases of familial polycystic kidney disease or rare collagen disease. A dissection nearly always occurs in the extracranial portion of the vertebral artery or carotid artery; exclusively intracranial dissections are very rare. They typically occur after sporting activity or chiropractic treatment (manipulation), but they can also be triggered by unremarkable events, such as coughing or sneezing or hyperextension of the neck. Often, the trauma that gives rise to the dissection is so trivial that the patient cannot even recall it. It is unclear whether preexisting vessel wall abnormalities are involved, but there is an association with connective tissue disease. Patients will often report pain in the neck or the back of the head (vertebral artery), or in the throat and face, or around the eye (carotid artery). Thickening of the vessel wall can result in total occlusion, causing haemodynamic infarction. However, it is more common for thrombosis to occur at the site of the vessel wall damage, leading to distal embolization and thus to cerebral infarction. Furthermore, a dissection of the ascending aorta can lead to a dramatic cerebral syndrome or serious cerebral infarction, depending on how extensive the dissection is and which vascular system is affected. It is important to consider a dissection diagnosis if a patient presents with cerebral symptoms accompanied by pain in the chest or in the shoulders and neck. A dissection of the descending aorta can cause infarction of the spinal cord (7sect. During injection of the contrast medium, the left carotid artery is closed by compression. Nevertheless, on the front view (a), the left middle cerebral artery can be seen running horizontally, due to the unimpaired function of the circle of Willis. The anterior cerebral arteries are also visible, running vertically in the centre of the image. Once a bolus of contrast medium has been injected, first the arteries can be imaged, then the capillary phase and finally the venous phase. Such angiography is not often performed for exclusively diagnostic purposes, because there is a small risk of complications. Their signal intensity is such that they cannot be distinguished from the background (which usually appears black). That is because the hydrogen protons in the blood flow out of the affected region during the relaxation phase (flow void). Nevertheless, if abnormalities in the minor cerebral arteries are suspected, conventional angiography remains the gold standard (. Diagnostic angiography is indicated mainly in cases where vascular malformation is suspected and non-invasive imaging has failed to yield sufficient information. However, angiographic techniques are also used for interventions such as the treatment of acute cerebral infarction where thrombosis has been identified in one of the basal cerebral arteries, the coiling of aneurysms (7sect. Duplex scanning enables the visualization of a cross-section of blood vessels, revealing any plaque formation and thrombosis (. Although the results are slightly less reliable than those attainable by angiography, ultrasound techniques are suitable for selecting patients for carotid artery desobstruction endarterectomy. Indeed, with an experienced team, ultrasound is sufficiently reliable to be used in the endarterectomy procedure itself, without the need for additional imaging. Transcranial Doppler scanning can be used to measure the speed and direction of flow in the basally located major blood vessels. However, it is a technically more difficult procedure and not always possible, due to the temporal bone having no window. The blood is flowing from right to left; the blood flow is being impeded at the start of both the external carotid artery and the internal carotid artery by the presence of calcified plaque. The vascular lumen of the internal carotid artery is locally reduced by about 75 %. The technique can also be used to get an impression of the number of micro-embolisms passing through the middle cerebral artery (high-intensity transient signals or microembolic signals). The penumbra may be identified as the region in which perfusion is reduced, but not sufficiently so to appear abnormal on a diffusion scan. If the region of reduced perfusion is the same size as the region of abnormal diffusion, there is no penumbra, and the entire region will almost certainly succumb to infarction. The results provide a picture of the residual blood flow through the affected tissues. Many muscular diseases have a genetic cause and are almost untreatable, but this is why it is very important to recognize acquired diseases, as a good deal can usually be done about them therapeutically. When classifying muscular diseases a distinction needs to be made between proximal and distal myopathies, and between diseases with and without myotonia. Myasthenia is a special case: unlike most other muscular diseases it often causes diplopia, and the severity of the symptoms fluctuates. Myasthenias are usually autoimmune diseases and as such respond well to treatment, but incorrect treatment can cause lifethreatening situations. In cases of muscular disease care needs to be taken with anaesthesia and good genetic advice must be given. Immediately after delivery the child was very feeble and had little facial expression and a drooping mouth. She had had a cataract operation at the age of 25, but there were other cases of that at a young age in her family. On examination she was not able to relax quickly after clenching her fingers, and there was a transient muscle contraction when the thenar eminence was tapped with a reflex hammer. It was also noticeable that she had slight ptosis of the upper eyelids and could not close her eyes tightly. Question 1: What is the name of the phenomenon of delayed relaxation of the hands after making a fist and after percussion Question 2: Is the presentation described typical of a muscular disorder or of a neurological disorder No sensory symptoms are found in three of the four groups (motor neuron diseases, myasthenia, and myopathy). In such cases it is often impossible to determine clinically without further tests whether the loss of strength is due to a myogenic or a neurogenic disorder. Myotonia is a symptom in a few primary muscular diseases, where percussion of the muscle or voluntary tensing causes post-contraction of that muscle lasting 3­10 seconds. In other diseases (Becker muscular dystrophy, mitochondrial myopathies) there is often cramp (7sect. In the efferent motor system we distinguish between: 5 Disorders of the cell body (soma) of the motor neuron. Although the cell body of the motor neurons is in the spinal cord, these diseases are nevertheless classified as neuromuscular. Most peripheral nerves contain axons of both motor and sensory fibres, which is why impaired sensation is often found in neuropathy, as well as loss of strength. The afferent system is made up of the sensory neurons, whose cell body is found in the dorsal sensory ganglia. Degenerative abnormalities will be found in the muscle biopsy, usually a genetic abnormality in the cytoskeletal proteins (7sect. There are also congenital myopathies where the presentation largely comprises contractions followed by inability to relax fully: myotonia. In acquired myopathies there is inflammation (myositis, often an autoimmune problem) or muscle damage due to endocrinological abnormalities or toxicity (medication). In the vast majority of cases myasthenias are acquired and therefore due to an autoimmune problem. Congenital muscular diseases usually manifest themselves before the 30th year and have a more chronic course than most acquired muscular diseases. A striking difference is that in congenital muscular diseases the neck muscles only become involved at a late stage, whereas this takes place at an earlier stage in acquired myopathies. The classic presentation is proximal weakness, which is worse in the legs than in the arms. Fairly rare are distal myopathies, which present with weakness of the foot extensors or flexors. Making a differential diagnosis for purely distal loss of strength can be very difficult. The cranial muscles are usually unaffected in a myopathy, except for the mitochondrial myopathies, which can cause severe weakness of the external eye muscles and ptosis. If the eyes are involved the possibility of myasthenia should always be considered. On the other hand, it is sometimes very difficult to ascertain whether the problem is myogenic or neurogenic. A muscle ultrasound can also distinguish between myogenic and neurogenic muscular disorders. This enzyme is normal or moderately elevated in neurogenic disorders, never elevated in myasthenia, and normal or moderately or highly elevated in muscular diseases (dystrophinopathy). Increased urine myoglobin levels (red urine without erythrocytes) are found after massive muscle breakdown or rhab domyolysis (due to major wounds or muscle ischaemia), after intoxications (alcohol, heroin, some medical drugs), in meta bolic myopathies, sometimes in severe polymyositis and as an episodic, sometimes familial, metabolic or genetic disorder. If a congenital metabolic disorder is suspected, enzyme functions should be tested. At first sight a muscle biopsy provides some information on the characteristics of myopathy and dystrophy (variable muscle fibre thickness, fat deposition); immunohistochemical staining can detect deficiencies in cytoskeletal proteins; biochemical staining can reveal metabolic abnormalities (. Electron microscopy can provide important information in the case of mitochondrial and congenital myopathies. If there is myositis there will be inflammation not only in muscle tissue but also in blood vessels. Dystrophin deficiency is due to a gene mutation on the short arm of the X chromosome; inheritance is X-linked recessive: a mother with this mutation runs a 50 % risk of having a son with muscular dystrophy and a 50 % risk of having a daughter who is a carrier. This disease causes delayed motor development, gradually producing a waddling gait with hyperlordosis. Some of these children have cognitive disorders: this is due not to delayed motor development but to the gene mutation in the dystrophin gene, which is also expressed in the brain. The disease is so progressive that children generally end up in a wheelchair between the 10th of 12th year of life (. The eye muscles and bulbar muscles remain unaffected for a long time, as does the diaphragm. Physiotherapy can prevent contractures, enabling the patient to remain mobile for 1­5 years longer. This may be due to the fact that this treatment increases the amount of muscle proteins, reduces the inflammatory reaction in the muscles and increases the stability of the muscle fibre membrane (sarcolemma). It does not appear to be due to an immunomodulatory effect, since other immunosuppressants do not work. Life prospects can be improved by surgical stabilization of the kyphoscoliosis of the spine, which often gets worse once the patient becomes dependent on a wheelchair. Nocturnal or permanent (non-invasive) respiratory support has made the biggest contribution to prolonging life so far.

Blood studies are generally unremarkable although occasionally anemia erectile dysfunction doctor orlando cheap zydalis 20 mg online, leukocytosis treatment for erectile dysfunction before viagra zydalis 20 mg purchase amex, and elevation of alkaline phosphatase and lactate dehydrogenase can be seen in osteosarcoma and Ewing sarcoma [10 erectile dysfunction medicine by ranbaxy buy on line zydalis,11] erectile dysfunction exercises discount 20 mg zydalis fast delivery. Sites of Presentation and Radiologic Considerations Optimal imaging of bone sarcomas depends on the anatomic site of involvement as they can arise in any bone and within any region of the given bone [12­14] erectile dysfunction in early 30s cheap zydalis 20 mg. For example, osteosarcoma typically arises as an intramedullary metaphyseal lesion and less commonly on the surface of long bones. Anatomic sites frequently involved include the lower extremities (65%), humerus (11%), pelvis (8%), and jaw (6%). Chondrosarcoma has a predilection for extremities, pelvis, scapula, and ribs [16]. It is important to remember that extraskeletal (or soft tissue) bone sarcomas without obvious bone involvement are not infrequently seen. Chordomas have historically been managed by orthopedic or neurosurgeons and classified as bone tumors, however they lack osteoid and arise from remnants of the embryonic notochord. Chordomas are restricted to the sacral spine (~35%), cervical or mobile spine (~30%), and clivus (~35%). Initial evaluation of a suspected bone lesion should include conventional Xray films with biplanar views. The pattern of bone destruction, soft tissue extension, and periosteal reaction helps narrow the differential diagnosis. Involving a musculoskeletal radiologist is critical to accurate diagnosis of suspected bone neoplasms. A differential diagnosis based on clinical presentation and imaging of the lesion can then guide next steps in aspects of obtaining a biopsy and staging. In patients who are less than 40 years old and who present with a primary bone lesion, further workup including biopsy should be performed at the treating institution, which should include clinicians with sarcoma expertise. For patients who are older than 40 years, additional workup to exclude metastatic spread from nonbone primaries is recommended. Metastases to brain are rare in sarcomas and therefore imaging is recommended only when there is a high clinical suspicion. Nuclear expression of T brachyury, a transcription factor, occurs in nearly all chordomas and very rarely in other bone neoplasms; it also occurs in some carcinomas and germ cell tumors but these are not likely to be confused with chordoma on clinical or morphologic grounds [9]. Given the rarity of primary bone tumors it is essential to confirm their diagnosis with an expert bone sarcoma pathologist. As tumors become more undifferentiated, the diagnosis becomes additionally challenging, resulting in disagreements even among expert pathologists [6]. Molecular characteristics have not been shown to be prognostic and are thus not incorporated in staging systems. Clinical Presentation and Diagnosis Localized pain, fracture, or enlarging mass are the most common signs and symptoms that patients present at the time of diagnosis. Pain is often localized and described as dull, deep seated, unremitting, and present at rest and worsened by motion or weight bearing. On examination, a localized soft tissue Sarcomas of Bone in Adults 621 Biopsy Considerations Biopsy is crucial for the diagnosis and management of bone sarcomas and requires experience in musculoskeletal oncology. Successful biopsy is based on accurate prebiopsy planning and meticulous execution. Since potentially catastrophic complications may derive from a poorly performed biopsy, a treating physician lacking substantial expertise in this field should always consider referral to a musculoskeletal oncologist before the biopsy. Although technically simple, biopsy is conceptually demanding and represents an essential part of the treatment strategy, requiring expertise at a sarcoma center. Biopsy should ideally follow adequate imaging and should be the last step to complete staging of the lesion [17]. Tissue may be obtained by an open surgical biopsy or a percutaneous technique using either a core needle or a fine needle. The use of imageguided percutaneous biopsy has greatly increased during the past two decades and represents the technique of choice for the majority of lesions in most centers with sarcoma expertise. Regardless of the technique, the fundamental principle of bone tumor biopsy is that it invariably also causes contamination of surrounding tissues, and the biopsy tract needs then to be removed en bloc with the tumor at the time of definitive surgery [18]. Inappropriate placement of the biopsy tract, postbiopsy hematoma with contamination of the neurovascular bundle, and use of transverse incisions remain unfortunately common errors in the management of musculoskeletal sarcomas, complicating definitive surgery by an increased risk of wound problems and local recurrence, often requiring more extensive resections, need for plastic surgery, and sometimes amputation rather than a limb salvage procedure [19]. The importance of tumor molecular profiling is rapidly growing, particularly for soft tissue sarcomas, and progressively translating from diagnosis to selection of targeted treatment. Imageguided percutaneous biopsy techniques are today effective in establishing a diagnosis in more than 90% of cases in large highvolume referral centers for musculoskeletal sarcomas. Imagebased guidance allows for proper access, avoidance of neurovascular structures, and targeting of the most viable, solid tissue for diagnosis, avoiding central areas of necrosis and cystic changes [20,21]. Even though core biopsy has shown superior diagnostic accuracy, refinement in performance and interpretation of fineneedle aspiration has allowed successful clinical application, particularly when performed during an office visit to obtain timely confirmation or exclusion of malignancy and/ or recurrence [22]. Nodal involvement is rare in bone sarcoma and only notated when lymph nodes have disease involvement. There are four grades of differentiation: not assessable (Gx), well (G1), moderately (G2), and poorly (G3) differentiated. Some histological types of bone sarcomas are graded according to cellularity, atypia, mitotic activity, necrosis, and degree of differentiation, whereas others are assigned a grade based entirely on the histological type. The biopsy tract may be easily incorporated in the ideal incision for surgical resection. Note that the hemorrhagic subcutaneous infiltration extends distally involving the entire arm. Primary Multimodality Treatment Surgery Current treatment for lowgrade sarcomas is primarily surgical. However, highgrade lesions require multimodal management, including radiotherapy and/or chemotherapy. Even in high grade tumors, however, the role of surgery remains pivotal in the overall management. The amount of normal tissue required as a margin to avoid local recurrence may vary according to the grade of malignancy, histologic type, and pattern of tumor growth. More importantly, it is inversely proportional to the use of a locally effective adjuvant modality of treatment in association with surgery. These principles, associated with contemporary imaging modalities and surgical reconstructive techniques, have translated in routine performance of limb salvage surgery rather than amputation in approximately 85­90% of cases in large referral centers. The goal of limb salvage is to obtain at the same time satisfactory local control of the primary tumor (the higher priority) and preservation/restoration of a functional limb. Surgery is the only treatment modality for lowgrade bone sarcomas such as most chondrosarcomas and, less commonly, central or juxtacortical osteosarcomas. They are managed by wide en bloc excision and reconstruction as needed to restore weightbearing bone, joints, adequate soft tissue coverage, and ultimately function. Metal implants, allografts, vascularized autografts, rotational and free flaps are variously associated to encompass a variety of different clinical settings. When compared to the prechemotherapy era, 5year survival has dramatically improved from 5­15% to current 65­75% [25,26]. Preoperative (or neoadjuvant) systemic chemotherapy is regarded today as the most effective means of decreasing local extent of highgrade bone sarcomas in order to facilitate limb salvage surgery. This requires clear communication between the surgeon and pathologist regarding orientation of the specimen. In (a), the ink is resting on normal fibroadipose tissue, determining a "wide" or "negative" margin. In (b), the ink lies on tumor tissue, determining an "intralesional" or "positive" margin, unsatisfactory for local control because associated with increased risk of local recurrence. This patient could not be managed by limbsalvage surgery and underwent forequarter amputation with anterosuperior chest wall resection and reconstruction. The surgical and reconstructive principles applied in highgrade bone sarcomas are essentially the same as for lowgrade tumors. It is important to consider the advantages of surgery after induction chemotherapy (decreased tumor vascularity and downstaging) and disadvantages (higher risk of wound problems and deep infection due to the immunocompromised status of the patient). Optimization of the timing for surgery and perioperative chemotherapy administration to minimize surgical complications is therefore an important consideration in the overall patient management. Radiotherapy Radiotherapy is frequently considered as either an adjuvant to surgery in the management of bone sarcomas or as an upfront primary therapy in unresectable cases, although its role in the latter situation is limited in lowgrade tumors and in osteosarcoma, where chemotherapy plays a much more important role. Following preoperative chemotherapy, extensive ossification (b) and delimitation of the lesion towards soft tissues has occurred (c), facilitating a difficult but possible en bloc excision of the proximal humerus and glenoid. Charged particle beams such as proton beam radiotherapy have long been utilized for the treatment of tumors of the axial skeleton such as chondrosarcomas, chordomas, and spine sarcomas [29,30]. These small cell tumors are radiosensitive, and doses of irradiation of 45­55 Gy have been effective as primary local therapy. Radiotherapy is often recommended in lieu of surgery as local therapy for these tumors in cases where wide surgical resection would result in unacceptable loss of function or deformity [31]. Radiotherapy should especially be considered in resected tumors with positive margins. Long term complications of radiotherapy may include soft tissue atrophy, bone necrosis, pathologic fracture, growth plate arrest with limb shortening in skeletally immature patients, soft tissue 626 Bone and Soft Tissue Tumors (a) (c) (b) There are few studies in adults to support this extrapolation and minimal retrospective data on the outcomes of adult patients with bone sarcomas treated with systemic chemotherapies [33]. In pediatric studies that include a wide age range of patients, increasing age is an adverse prognostic factor. In these studies, the benefits of systemic chemotherapies or dose intensity are seen in children younger than 15­18 years and less pronounced in older cohorts [34,35]. Similarly, in studies exploring dosedense (2 vs 3week) cycles with multiagent chemotherapies. Chondrosarcoma, chordoma, and giant cell tumor of bone are primarily seen in adults rather than children. Rare and more aggressive osteosarcoma subtypes such as osteosarcoma associated with Paget disease, small cell, dedifferentiated paraosteal, and highgrade surface variants are much more common in adults than in children. Since there are limited prospective or randomized data, treatment of adults with these tumors is often based on expert consensus guidelines such as those of the National Comprehensive Cancer Network [13,14]. Discussions about fertility preservation and timely referral should be considered in all patients greater than 12 years of age. When possible, patients should be referred to a tertiary care center with sarcoma expertise. Dramatic response to preoperative chemotherapy (b), with substantial tumor shrinkage, particularly of the soft tissue component. Local management consisted of en bloc resection of the distal tibia and tibio talar joint, followed by reconstruction with bone allograft and multiple fixation (c). Both conventional and imageguided focal radiation can benefit patients who suffer from complications of metastases. Highdose focal radiotherapy in particular is emerging as an effective palliative modality for radioresistant tumors in the spine and offers benefit for patients with metastatic disease who have limited options for systemic treatment [32]. As previously noted, in most cases lowgrade osteosarcomas do not require systemic chemotherapy. In localized, highgrade osteosarcoma, the cure rate with surgery alone is less than 15­20%. Addition of multiagent chemotherapy in the neoadjuvant or adjuvant setting improves this cure rate to 50­75%, recognizing that outcomes are inferior in older patients as either a reflection of variant biology, comorbidities, or inability to receive dosedense chemotherapy [14]. Factors that are associated with poor outcomes include older age, male sex, axial skeleton involvement, large tumor size, and poor response to chemotherapy [36]. Chemotherapy should be offered to all patients after careful consideration of comorbidities and risks of chemotherapy. The backbone of chemotherapy is a doublet of Adriamycin (doxorubicin at 60­75 mg/m2) and cisplatin (90­120 mg/m2) administered intravenously over several days, recognizing that there are several protocols with variable routes of administration and schedules. In pediatric protocols, the standard of care is a threedrug regimen with addition of high dose methotrexate to Adriamycin and cisplatin. In adults, highdose methotrexate can frequently result in delay in administering doublet due to slow clearance of methotrexate and resultant renal dysfunction, myelosuppression, and/or mucositis. In localized osteosarcoma, there is no survival difference on the sequence (neoadjuvant or adjuvant) of administering chemotherapy [37]. The advantages of chemotherapy in the neoadjuvant setting are the opportunity to gauge the effect of chemotherapy (degree of necrosis) in the resected tumor and increasing likelihood that the patient will be a candidate for limbsparing surgery. Tumors with >90% necrosis ("good responders") have improved overall survival than those Sarcomas of Bone in Adults 627 with <90% necrosis ("poor" responders) [14,36]. In an effort to improve survival outcomes in "poor" responders, various chemotherapies, notably ifosfamide and etoposide, have been used in the postoperative setting. However, retrospective data from single institutions in adult patients suggested that addition of ifosfamide in "poor" responders improved outcomes [26,27,39]. In the metastatic setting, either at the time of initial presentation or at recurrence, active agents include doxorubicin, cisplatin, highdose methotrexate, ifosfamide, gemcitabine, docetaxel, and the combination of oral sorafenib (a multityrosine kinase inhibitor) and everolimus [14,40]. Surgery may be appropriate in select patients with a low burden of metastatic disease and who demonstrate durable disease stability [14]. Chondrosarcoma Chemotherapy is not effective in chondrosarcoma, particularly with conventional subtypes. The role of adjuvant chemotherapy is controversial in dedifferentiated and mesenchymal subtypes. Clinical trials are strongly encouraged for patients who are considering systemic therapies. The treatment paradigm is 3­4 cycles of chemotherapy, followed by surgery for localized disease and additional chemotherapy for up to 17 cycles. In localized disease, cure rates with surgery or radiation alone are less than 15% and increase to 70% with the addition of multiagent chemotherapy. Similar to osteosarcoma, advancing age (>15 years), larger size, and axial/pelvic location are associated with worse outcomes. Adults rarely tolerate 17 cycles or a doseintense regimen (2 vs 3 weeks) and treating oncologists arbitrarily consider 10­14 cycles as adequate. Cyclophosphamide can have higher hematological toxicities while ifosfamide can have higher renal tubular dysfunction and therefore the choice of agents can be altered based on comorbidities.

References

• Cunningham D, Allum WH, Stenning SP, et al, MAGIC Trial Participants: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11, 2006.
• Vardy JM, Dignon N, Mukherjee N, et al: Audit of the safety and effectiveness of ketamine for procedural sedation in the emergency department. Emerg Med J 25:579-582, 2008.
• Chromecki TF, Cha EK, Fajkovic H, et al: The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy, Eur Urol 61(2):245n253, 2012.
• Silbert PL, Mokri B, Schievink WI. Headache and neck pain in spontaneous internal carotid and vertebral artery dissections. Neurol 1995;45:1517.
• Carson IW, Moore J, Balmer JP, et al. Laryngeal competence with ketamine and other drugs. Anesthesiology 1973;38:128-133.
• Mondon CE, Dolkas CB, Reaven GM. Effect of acute uremia on insulin removal by the isolated perfused rat liver and muscle. Metabolism. 1978;27:133-142.